Roy Strowd to Neoplasm Recurrence, Local
This is a "connection" page, showing publications Roy Strowd has written about Neoplasm Recurrence, Local.
Connection Strength
1.510
-
Strowd RE, Abuali I, Ye X, Lu Y, Grossman SA. The role of temozolomide in the management of patients with newly diagnosed anaplastic astrocytoma: a comparison of survival in the era prior to and following the availability of temozolomide. J Neurooncol. 2016 Mar; 127(1):165-71.
Score: 0.454
-
Strowd RE, Salvatori R, Laterra JJ. Temozolomide retreatment in a recurrent prolactin-secreting pituitary adenoma: Hormonal and radiographic response. J Oncol Pharm Pract. 2016 Jun; 22(3):517-22.
Score: 0.425
-
Merrill R, Puckett M, Morrow WP, Hsi ED, Powell J, Li Z, Vaidya R, Strowd R. Clinical Reasoning: A 65-Year-Old Woman With Cancer History and Wrist Drop. Neurology. 2022 Sep 27; 99(13):570-576.
Score: 0.178
-
Holdhoff M, Ye X, Piotrowski AF, Strowd RE, Seopaul S, Lu Y, Barker NJ, Sivakumar A, Rodriguez FJ, Grossman SA, Burger PC. The consistency of neuropathological diagnoses in patients undergoing surgery for suspected recurrence of glioblastoma. J Neurooncol. 2019 Jan; 141(2):347-354.
Score: 0.138
-
Markowski MC, Wobker SE, Strowd RE, Antonarakis ES. Lumbosacral Plexus Involvement as the First Site of Metastatic Recurrence in a Patient With CTNNB1-Mutant Prostate Cancer. Clin Genitourin Cancer. 2016 08; 14(4):e417-22.
Score: 0.115
-
Strowd RE, Abuali IA, Grossman SA. Objective cerebrospinal fluid response to intraventricular rituximab in indolent CNS lymphoma. CNS Oncol. 2015; 4(3):131-5.
Score: 0.108
-
Strowd RE, Blackwood R, Brown M, Harmon M, Lovato J, Yalcinkaya T, Lesser G. Impact of temozolomide on gonadal function in patients with primary malignant brain tumors. J Oncol Pharm Pract. 2013 Dec; 19(4):321-7.
Score: 0.092